Cystic fibrosis

E-poster session
Chairs: N. Simmonds (London, United Kingdom), S. Fustik (Skopje, North Macedonia)

Temporal trends in costs of care for cystic fibrosis in France E. Van Ganse (Lyon, France), F. Dalon (Lyon, France), L. Lemonnier (Paris, France), C. Dehillotte (Paris, France), Q. Reynaud (Pierre-Bénite, France), M. Bérard (Lyon, France), D. Walther (Lyon, France), M. Belhassen (Lyon, France), I. Durieu (Pierre-Bénite, France)
Screening of Depression and Anxiety Disorders in Cystic Fibrosis Patients and Their Parents P. Ergenekon (Istanbul, Turkey), C. Yegit (Istanbul, Turkey), H. Mursaloglu (Istanbul, Turkey), Y. Gokdemir (Istanbul, Turkey), E. Erdem Eralp (Istanbul, Turkey), F. Karakoc (Istanbul, Turkey), B. Karadag (Istanbul, Turkey)
Should the D1152H variant be included in cystic fibrosis newborn screening programmes? C. Dafydd (Cardiff, United Kingdom), K. Southern (Liverpool, United Kingdom), S. Moat (Cardiff, United Kingdom), I. Doull (Cardiff, United Kingdom)
Cystic fibrosis newborn screening for R117H in England C. Dafydd (Cardiff, United Kingdom), S. Moat (Cardiff, United Kingdom), K. Southern (Liverpool, United Kingdom), I. Doull (Cardiff, United Kingdom)
Description of new CFTR gene’s mutations in patients of Russia Y. Gorinova (Moscow, Russian Federation), K. Savostyanov (Moscow, Russian Federation), O. Simonova (Moscow, Russian Federation), S. Krasovskyi (Moscow, Russian Federation)
First identified “severe” mutations and extended rearrangements in the CFTR gene in Russian cystic fibrosis patients E. Kondratyeva (Moscow, Russian Federation), N. Petrova (Moscow, Russian Federation), S. Krasovsky (Moscow, Russian Federation), A. Zodbinova (Moscow, Russian Federation), Y. Melyanovskaya (Moscow, Russian Federation), M. Starinova (Moscow, Russian Federation), A. Chernyak (Moscow, Russian Federation), R. Zinchenko (Moscow, Russian Federation), S. Kutsev (Moscow, Russian Federation)
CFTR mutations unidentified in CFTR2 database and their phenotypic characteristics: Data from cystic fibrosis registry of Turkey G. Cinel (Ankara, Turkey), D. Dogru (Ankara, Turkey), E. Çakir (Istanbul, Turkey), T. Sismanlar Eyüboglu (Ankara, Turkey), N. Çobanoglu (Ankara, Turkey), S. Pekcan (Konya, Turkey), E. Yalçin (Ankara, Turkey), N. Kiper (Ankara, Turkey), V. Sen (Diyarbakir, Turkey), H. Selimoglu Sen (Diyarbakir, Turkey), Ö. Ercan (Konya, Turkey), Ö. Keskin (Gaziantep, Turkey), S. Bilgiç Eltan (Gaziantep, Turkey), L. Muhammed Al Shadfan (Istanbul, Turkey), H. Yazan (Istanbul, Turkey), D. Altintas (Adana, Turkey), S. Sasihüseyinoglu (Adana, Turkey), N. Sapan (Bursa, Turkey), S. Çekiç (Bursa, Turkey), H. Çokugras (Istanbul, Turkey), A. Ayzit Atabek (Istanbul, Turkey), T. Ramasli Gürsoy (Ankara, Turkey), A. Aslan (Ankara, Turkey), A. Bingöl (Antalya, Turkey), A. Basaran (Antalya, Turkey), A. Özdemir (Mersin, Turkey), M. Köse (Kayseri, Turkey), M. Hangül (Kayseri, Turkey), N. Emiralioglu (Gaziantep, Turkey), G. Tugcu (Ankara, Turkey), H. Yüksel (Manisa, Turkey), Ö. Yilmaz (Manisa, Turkey), F. Orhan (Trabzon, Turkey), Z. Gayretli aydin (Trabzon, Turkey), E. Topal (Malatya, Turkey), Z. Tamay (Istanbul, Turkey), A. Süleyman (Istanbul, Turkey), D. Can (Balikesir, Turkey), C. Bal (Erzurum, Turkey), G. Çaltepe (Samsun, Turkey), U. Özçelik (Ankara, Turkey)
Cystic Fibrosis: Clinical profile of 10 patients with R334W mutation compared to ?F508 homozigoty S. Moura Cabral (Coimbra, Portugal), J. Oliveira Pereira (Coimbra, Portugal), B. Gonçalves (Coimbra, Portugal), F. Gamboa (Coimbra, Portugal)
Clinical presentation in CF patients with large deletions G. Petrova (Sofia, Bulgaria), N. Yaneva (Sofia, Bulgaria), M. Libik (Prague, Czech Republic), D. Miteva (Sofia, Bulgaria), B. Gospodinova (Sofia, Bulgaria), M. Nikolova (Varna, Bulgaria), P. Perenovska (Sofia, Bulgaria), M. Macek Jr (Prague, Czech Republic), A. Savov (Sofia, Bulgaria)
Spectrum of CFTR mutations in Republic of North Macedonia S. Fustik (Skopje), D. Plaseska Karanfilska (Skopje), M. Terzikj (Skopje), L. Spirevska (Skopje), A. Stamatova (Skopje)
Bioenergetics of breathing in children with cystic fibrosis: a thermodynamic study J. Çatak (Istanbul, Turkey), E. Develi (Istanbul, Turkey), S. Bayram (Istanbul, Turkey)
Dehydration and electrolyte imbalance: a common presenting manifestation of cystic fibrosis in Cyprus P. Anagnostopoulou (Nicosia, Cyprus), A. Matthaiou (Nicosia, Cyprus), P. Kouis (Nicosia, Cyprus), V. Neocleous (Nicosia, Cyprus), T. Adamidi (Nicosia, Cyprus), P. Ioannou (Nicosia, Cyprus), P. Fanis (Nicosia, Cyprus), C. Costi (Nicosia, Cyprus), A. Georgiou (Nicosia, Cyprus), L. Phylactou (Nicosia, Cyprus), P. Yiallouros (Nicosia, Cyprus)
Low-dose chest CT for bone mineral density in pediatric patients with cystic fibrosis L. Pinto (Porto Alegre (RS), Brazil), R. Andrade (Porto Alegre (RS), Brazil), G. Forte (Porto Alegre (RS), Brazil), B. Hochhegger (Porto Alegre (RS), Brazil)
Midregional proadrenomedullin in patients with cystic fibrosis lung disease: a pilot study V. Shmarin ( Moscow, Russian Federation), D. Pukhalskaya ( Moscow, Russian Federation), T. Kuznetsova ( Moscow, Russian Federation), S. Krasovsky ( Moscow, Russian Federation), S. Semykin ( Moscow, Russian Federation), M. Usacheva ( Moscow, Russian Federation), G. Shmarina ( Moscow, Russian Federation), V. Alioshkin ( Moscow, Russian Federation)
PLEURO-PULMONARY COMPLICATIONS IN PATIENTS WITH CYSTIC FIBROSIS L. Balanetchi (Cluj-Napoca (Cluj), Romania), R. Selevestru (Chisinau, Republic of Moldova), E. Gudumac (Chisinau, Republic of Moldova), S. Sciuca (Chisinau, Republic of Moldova)
Impact of flash glucose monitoring system in cystic Fibrosis related diabetes S. Rahman (Cambridgeshire, United Kingdom), J. Mcdermott2 (Cambridgeshire, United Kingdom), A. Adler (Cambridgeshire, United Kingdom), H. Barker (Cambridgeshire, United Kingdom), C. Johnson (Cambridgeshire, United Kingdom), D. Grogono (Cambridgeshire, United Kingdom), U. Hill (Cambridgeshire, United Kingdom), C. Haworth (Cambridgeshire, United Kingdom)
Expression and function of murine WFDC2 in the respiratory tract. L. Bingle (Sheffield (South Yorkshire), United Kingdom), H. Armes (Sheffield (South Yorkshire), United Kingdom), C. Bingle (Sheffield (South Yorkshire), United Kingdom)
Epidemiology and factors associated with overweight in adults with cystic fibrosis: an Italian multicenter experience. A. Gramegna (Milano (MI), Italy), S. Aliberti (Milano (MI), Italy), M. Contarini (Milano (MI), Italy), D. Savi (Milano (MI), Italy), F. Ciciriello (Milano (MI), Italy), F. Maio (Milano (MI), Italy), V. Lucidi (Milano (MI), Italy), P. Palange (Milano (MI), Italy), F. Blasi (Milano (MI), Italy)